138 results
8-K
EX-99.1
MRK
Merck & Co Inc
25 Apr 24
Merck Announces First-Quarter 2024 Financial Results
6:41am
are harnessing the power of innovation to advance our deep pipeline and are maximizing the impact of our broad commercial portfolio for the benefit of patients
PX14A6G
Bowyer Research, Inc.
27 Mar 24
Letter to shareholders
8:57pm
create two primary harms. First, they stifle viewpoint diversity, robust dialogue, and innovation. Second, they reduce the ability of a company to attract … will promote innovation and collaboration, attract the broadest set of talent, and align the company with the diverse views of the company’s stakeholders.33
8-K
EX-99.1
srb xtwkgt0zphhvlt5l
26 Oct 23
Merck Announces Third-Quarter 2023 Financial Results
6:38am
8-K
EX-99.1
q202mc1ve4ysvg9dsb7
1 Aug 23
Merck Announces Second-Quarter 2023 Financial Results
6:46am
PX14A6G
r549t kaw6vw
12 Apr 23
Letter to shareholders
8:58am
8-K
EX-99.1
43zx9yfvipo
27 Oct 22
Merck Announces Third-Quarter 2022 Financial Results
6:38am
8-K
EX-99.3
9aag96q20 o9
27 Oct 22
Merck Announces Third-Quarter 2022 Financial Results
6:38am
424B5
h0d yjq6yfdz7yssl8
9 Dec 21
Prospectus supplement for primary offering
4:37pm
424B5
52vbib377s75
7 Dec 21
Prospectus supplement for primary offering
8:13am
8-K
EX-99.1
ar8fsp
28 Oct 21
Merck Announces Third-Quarter 2021 Financial Results
6:40am
8-K
EX-99.1
o3mxnm1hi9lwkq1ubj0y
29 Apr 21
Merck Announces First-Quarter 2021 Financial Results
6:38am